A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Oxymorphone
Pitolisant
The serum concentration of Odanacatib can be decreased when it is combined with Pitolisant.
Oxymorphone
Apalutamide
The serum concentration of Odanacatib can be decreased when it is combined with Apalutamide.
Oxymorphone
Vemurafenib
The serum concentration of Odanacatib can be increased when it is combined with Vemurafenib.
Oxymorphone
Mometasone furoate
The metabolism of Odanacatib can be decreased when combined with Mometasone furoate.
Oxymorphone
Fluticasone
The metabolism of Odanacatib can be decreased when combined with Fluticasone.
Oxymorphone
Trametinib
The metabolism of Odanacatib can be decreased when combined with Trametinib.
Oxymorphone
Fluticasone furoate
The metabolism of Odanacatib can be decreased when combined with Fluticasone furoate.
Oxymorphone
Gemfibrozil
The metabolism of Odanacatib can be decreased when combined with Gemfibrozil.
Oxymorphone
Lenvatinib
The metabolism of Odanacatib can be decreased when combined with Lenvatinib.
Oxymorphone
Teriflunomide
The metabolism of Odanacatib can be decreased when combined with Teriflunomide.
Oxymorphone
Lumacaftor
The serum concentration of Odanacatib can be decreased when it is combined with Lumacaftor.
Dexfenfluramine
Berotralstat
The serum concentration of Berotralstat can be increased when it is combined with Safinamide.
Dexfenfluramine
Satralizumab
The serum concentration of Safinamide can be decreased when it is combined with Satralizumab.
Dexfenfluramine
Oliceridine
The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Safinamide is combined with Oliceridine.
Dexfenfluramine
Abametapir
The serum concentration of Safinamide can be increased when it is combined with Abametapir.
Dexfenfluramine
Tucatinib
The metabolism of Tucatinib can be decreased when combined with Safinamide.
Dexfenfluramine
Ozanimod
Safinamide may decrease the excretion rate of Ozanimod which could result in a higher serum level.
Dexfenfluramine
Rimegepant
The serum concentration of Rimegepant can be increased when it is combined with Safinamide.
Dexfenfluramine
Perphenazine enanthate
The risk or severity of extrapyramidal symptoms can be increased when Safinamide is combined with Perphenazine enanthate.
Dexfenfluramine
Dixyrazine
The risk or severity of extrapyramidal symptoms can be increased when Safinamide is combined with Dixyrazine.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3